- Home
- BNBX vs TOVX Comparison
BNBX vs TOVX Comparison
Compare BNBX & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNBX | TOVX |
|---|---|---|
| Founded | 1983 | 2001 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5M | 6.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BNBX | TOVX |
|---|---|---|
| Price | $0.75 | $0.18 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 81.3K | ★ 1.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $253.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.74 | $0.17 |
| 52 Week High | $128.55 | $1.75 |
Technical Indicators
Market Signals| Indicator | BNBX | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | 27.87 | 44.84 |
| Support Level | $0.74 | $0.18 |
| Resistance Level | $0.90 | $0.21 |
| Average True Range (ATR) | 0.16 | 0.02 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 8.97 | 28.00 |
Price Performance
Historical ComparisonAbout BNBX Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.